APGE - Apogee Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.132B

Cash

125.1M

Avg Qtr Burn

-10.76M

Short % of Float

3.96%

Insider Ownership

9.39%

Institutional Own.

44.37%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
APG777 Details Atopic dermatitis	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.